ITU Experts Group Thierry Zylberberg, Executive Vice President Orange, General Manager of Orange Healthcare September 2012.

ITU Experts Group

Thierry Zylberberg, Executive Vice President Orange, General Manager of Orange Healthcare

September 2012

2

agenda

part 1frameworks for m-health

part 2concrete case

part 3challenges and opportunities

3

reality…

Worldwide, between 2010 and 2050,

people aged 60 and more : +100 %1

People aged 80 and more : +100 %1

Between 2000 and 2050, share of the

dependent population: + 25 % in OECD countries

Spending for seniors to double or more by 2050,

says OECD

Chronic Disease Direct costs:Asthma: b$17.7 in Europe3

Diabetes: b$92 in USA3

Heart Failure: b$37 in USA4

Half of Brazil population said to have at least 1 chronic disease

In India, by 2015, 59% ofthe total deaths would

be due to NCDs

Healthcare expenditure in OECD countries +5%/year

France : 11% of GDPUSA : 15,3% of GDPGermany : 10,7% of

GDP says OCED

~30% of drugs of any given medicine can

be fake in Africa2

1 : accord the WHO, 20112 : according the WHO. (Source: The Times-UK, February, 2009)3: IDATE, sur la base du WHO 2009 ; OECD 2009 ; US Census 2009 ; Eurostat 20094: Home Monitoring for Heart Failure Management, Anh L. Bui, MD, Gregg C. Fonarow, MD Los Angeles, California, Journal of the American College of Cardiology Vol. 59, No. 2, 2012

1- frameworks for m-health

4

1- frameworks for m-health

technology…

low costs phenotypes

big datatechnologies

web 2.0, Internet

technologies

always ontechnologies

predictivemedicine

multiple factorstreatment or

diagnosis

be with the patienteverywhere,

anytime

patientempowerment

5

1- frameworks for m-health

Press & Portals

Web 2.0

CRM

New business model

Disruptive technologies

…in a complex ecosystem…

6

…a framework

health

professionals

patients

&

health professionals

patients

&

patients

BtoB

BtoGBtoC

business

model

medical data

compliance

medical medical consumerusage

Orange Healthcare©

Bto BG C

2

1- frameworks for m-health

7

business modelyet to

be found

healthaccess

healthefficiency

new busine

ss model

stablebusines

smodel

Cloud-Imagery

Drugs authentification

Health-line

ConnectedHospital

CDRMCloud-EHR

Health data hosting

Remote consultation (video

conf.)

DiabeticPatient follow

up

Appointment reminder

...another framework

1- frameworks for m-health

Toll-free emergency

Health surveys surveillance

8

Orange Value Chain

Health Applicati

ons

Healthcare ecosystem

Health “Computing”

(hosting)

PartnersPartners

Patients

Medical Devices

Consulting, Integration

M2M, International backbones &

Last mile

Global Integration, Helpdesk, services to end users

Specific developments (Security,

portals)

e-health, an ecosystem in mutation requires cooperation

1- frameworks for m-health

9

case 1 of partnership: Sanofi and Orange

2- concrete case

10

DiabeTIC Platform. Bidirectional communication between HCP & Patients

Mobile Computer

Patients with BGStar or iBGStar

Patient with other BGMs

Storage and analysis

HCPPATIENT

DNE

Available to all patients (not only i/BGStar patients)

2- concrete case

11 Orange Healthcare – TWC 2011

case 2 of partnership: mPedigree and Orange

2- concrete case

12

SMS based solution allowing to check if taken drug is counterfeit or authentic.

Easy-to-use solution, immediate response

Implemented in Kenya

counterfeit medicine solutionOrange and mPedigree are fighting counterfeit medicines

2- concrete case

13

challenges and opportunities

3- challenges and opportunities

1st challenge: business model

B2G or B2B2C or

B2C?

How can consumers be educated about and persuaded to use such a service?

How can pharmacist be incentivized

to positively promote such a service?Who will fund services?

Can pharmas finance services? Why?

Does a government need to constrain the installation of a

service ?

Is the system open to abuse – such as counterfeiters providing bogus SMS

checking numbers themselves?

What other kinds of similar services

could be developed?

3- challenges and opportunities

15

2nd challenge: dilution of responsibility, value chain complexity

Mobile Computer

Patients with BGStar or iBGStar

Patient with other BGMs

Storage and analysis

HCPPATIENT

DNE

connectivity

3- challenges and opportunities

16

3rd challenge: regulation

3- challenges and opportunities

17

Thank you